Atlas Trials

Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment

Clinical trial NCT02253251 · RECRUITING

Trial details

NCT number
NCT02253251
Sponsor
MiraKind
Status
RECRUITING
Study type
OBSERVATIONAL
Cancer
Start date
2014-09-01
Primary completion
2030-12-01
Enrollment
15000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.